TP53 and cancer: In contrast, in low SVCT-2 expressing cell lines, high-dose L-ascorbic acid exhibited anti-cancer effects as evidenced by expression of p53, whereas low-dose L-ascorbic acid treatment induced genes associated with cell proliferation.